ICON is a leading Contract Research Organization (CRO) that offers a comprehensive range of clinical consulting and commercial services across various sectors, including biotech, pharmaceuticals, medical devices, and government health. With expertise in therapeutic areas such as oncology, infectious diseases, and rare orphan diseases, ICON is dedicated to accelerating drug development and enhancing research and development returns on investment.

The company is committed to innovation in clinical trials, utilizing advanced technologies and patient-centric approaches to transform the research landscape. Through its ICON Cares program, the organization actively promotes sustainability, inclusion, and positive community impact as part of its mission to improve global healthcare outcomes.

Generated from the website